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Abstract 
Infectious sepsis (IS) is the result of a complex infection that is difficult to identify, 
diagnosis and treat. The gold standard for treatment of IS is early identification and 
intervention. There is a rise in patients with IS along with a concurrent rise of adults with 
Diabetes Mellitus (DM). Adults with DM are more susceptible to acute illness due to the 
multiple body systems affected by DM. Acute illness in adults with DM leads to 
increased blood glucose levels that become difficult to treat. Extreme elevations of blood 
glucose are linked to longer lengths of stay and higher mortality rates in adults with IS. 
Surviving Sepsis Campaign recommends blood glucose levels to be controlled below 
180mg/dl for all adults with and without diabetes. The purpose of this research study was 
to identify if a relationship exists between hyperglycemia, hyperlactatemia, hospital 
length of stay and mortality rates in septic adults with diabetes (Group A) and without 
diabetes (Group B).  Findings of the study did not project what was predicted regarding 
hyperglycemia, however high lactate levels were associated with longer lengths of stay 
and higher mortality rates as predicted.  This retrospective, two group design study found 
adults without diabetes had longer lengths of stay and higher mortality rates than adults 
with diabetes indicating poorly controlled glucose levels in nondiabetic adults with sepsis 
may impact patient outcomes. APRN’s can be instrumental in implementing change in 
patient care and hospital policy by providing evidenced based practice by following 
practice standards established at a national level such as the Surviving Sepsis Campaign.  
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EFFECTS OF HYPERGLYCEMIA ON ADMITTED ADULTS WITH SEPSIS 
Background/Statement of the Problem 
Infectious sepsis (IS) is the result of a complex infection that is not only difficult to 
predict and diagnose, but to treat as well (Center for Disease Control [CDC], 2015). Early 
identification and intervention is critical for adults presenting to the emergency 
department with bacteremia. Adult’s with IS manifest infection with systemic signs of 
inflammation and vital organ dysfunction, and remain at greater risk of death than those 
suffering from uncomplicated infections. Septic adults are particularly prone to 
hyperglycemia and insulin resistance due to of a number of pathophysiologic changes 
associated with the infectious response. Higher rates of IS are causing a rise in national 
mortality rates. In order to prevent death and provide better outcomes, it is vital to 
examine the role glucose in hospitalized adults diagnosed with IS (Mayo Clinic, 2014).  
Every year more than one million adults in America will become septic, of which 
28-50% will die. The incidence is higher than prostate cancer, breast cancer and HIV-
AIDS combined.  Sepsis accounts for greater than 500,000 emergency department visits, 
750,000 hospitalizations, and 215,000 deaths per year in the United States. The number 
of sepsis cases in the United States has been on the rise, likely due to a combination of 
factors including an increased sepsis awareness, increased tracking of sepsis, an aging 
population, increased longevity of people living with chronic disease, the spread of 
antibiotic-resistant organisms, an upsurge in invasive procedures and the broad use of 
immunosuppressive and chemotherapeutic agents (CDC, 2015). 
In addition to the rising numbers of adults with sepsis, there is also a concurrent 
rise in the number of adults living with diabetes mellitus (DM).  Currently over 29 
million people live with DM in the United States, and one out of four are unaware they 
have the disease. Due to better treatment, people with diabetes are living longer than 
before. DM affects multiple body systems making adults more susceptible to many 
chronic and acute illnesses including sepsis. Acute illness in adults with DM leads to 
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increased sick days and elevations in blood glucose levels that are prolonged making the 
disease difficult to control. The risk of death is 50% higher for adults with DM than those 
without DM. Approximately $245 billion are spent annually on treatment of DM (Mayo 
Clinic, 2014). It is important to explore whether medical providers should consider 
hyperglycemia when creating a plan of care for a diabetic versus a non-diabetic adults 
diagnosed with IS. Little is known about the impact hyperglycemia has on sepsis and the 
effects on the severity of illness.  
Extreme elevations of blood glucose are associated with higher mortality rates in 
various groups of hospitalized adults. The use of continuous insulin infusions, known as 
intensive insulin therapy (IIT), improves outcomes in a selected group of critically ill 
patients with the aim of normoglycemic control (Ali et al., 2008). The current 
recommendation from the Surviving Sepsis Campaign (2008), includes insulin therapy to 
maintain glucose below 180 mg/dL in all septic patients. Glucose variability, rather than 
the glucose level, has also been shown to be a significant factor associated with in-
hospital mortality (Ali et al., 2008). Treatment and prevention of hyperglycemia has been 
advocated for subjects with sepsis (Surviving Sepsis Campaign, 2008). 
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Literature Review 
 A literature review was conducted utilizing the search engines of CINAHL and 
Pub Med databases. Key words searched and combined included sepsis, diabetes 
mellitus, hyperglycemia, stress hyperglycemia, intensive insulin, and general adaptation 
theory. Literature from 2000 to 2015 was searched. Key literature found in the search will 
be discussed. 
Introduction 
 It was once thought that acute hyperglycemia was a normal and beneficial 
response for critical illness by providing additional glucose to organs in need of increased 
energy during illness. Hyperglycemia during illness is now being recognized as a harmful 
response for some adults (Schuetz, Castro & Shapiro 2011; Kaufman, 2008). It is 
common to have stress-induced hyperglycemia for both diabetic and non-diabetic adults 
during critical illness, but the level of which elevated glucose becomes harmful is still 
being studied.  Adults with diabetes are at greater risk for not only developing infection, 
but becoming septic as well. The risk increases from two and half to six times as likely 
for a diabetic adult to become septic than a non-diabetic adult (Stegenga, Vincent, Vail, 
Xie, Hanley, Williams, Bernard, & Poll, 2010).  DM has the potential to alter the 
inflammatory and coagulation pathways and this makes DM an important comorbid 
condition to consider in the management of acute sepsis (Schuetz, Castro & Shapiro, 
2011; Stegenga et al., 2010) 
Sepsis  
 Sepsis, secondary to infection, is a potentially life-threatening event. When sepsis 
occurs, chemicals are released into the bloodstream to trigger an inflammatory response 
throughout the body. The inflammatory response triggers a cascade of changes in 
multiple organ systems and results in organ failure. Once these changes occur, septic 
shock develops causing low blood pressure, decreased vital organ perfusion which can 
lead to death. The patient must exhibit at least two of the following symptoms to be 
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diagnosed with sepsis: a core body temperature greater than 101˚F or less than 96.8˚F, 
heart rate greater than 90 beats per minute, respiratory rate greater than 20 breathes per 
minute, and probable or confirmed infection. Severe sepsis may be present if one of the 
following symptoms are present: significantly decreased urine output, abrupt change in 
mental status, decrease in platelet count, difficulty in breathing, abnormal heart pumping 
function and/or abdominal pain (Mayo Clinic, 2014). As part of the surviving sepsis 
campaign, 24 hour management bundle includes: blood product administration, 
immunoglobulin use, mechanical ventilation in acute respiratory distress syndrome, 
sedation or analgesia, glucose control, renal replacement therapy, bicarbonate therapy, 
deep venous thrombosis and stress ulcer prophylaxis, nutrition, and goal setting care. 
Surviving Sepsis Campaign (SSC) 2015, an international committee of expert’s 
consensus on the guidelines for management of severe sepsis and sepsis shock 
recommends to initiate insulin after two consecutive blood glucose levels greater than 
180mg/dl, with an upper limit set at 180mg/dl. Blood glucose values are to be monitored 
every one to two hours until below 180mg/dl, then monitored every four hours thereafter. 
Glucose levels obtained by point-of-care capillary blood are to be used with caution as 
values may not accurately reflect arterial blood or plasma blood values (Surviving Sepsis 
Campaign, 2015). 
IS has been an increasingly critical medical condition in the last decade, with an 
increased number of deaths occurring secondary to severe IS. IS accounts for more than 
500,000 emergency room visits, 751,000 hospitalizations, and 215,000 deaths per year in 
the United States (CDC, 2015; Ali et al., 2008; Michaels & Dorman, 2004).  A main goal 
for optimal sepsis management includes early recognition and treatment aimed at 
disrupting the pathway. The pathophysiology of sepsis and treatment guidelines are well 
established, therefore treatment should be standardized, including glucose control 
(Michaels & Dorman, 2004). 
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A review, conducted by Michaels & Dorman (2004), supported the need to apply 
evidence-based guidelines in the ICU to improve the outcomes of IS. The research was 
based on a retrospective chart review of 26 adults in medical and surgical ICU in an 
urban community hospitals from January 2003 to October 2003. Michaels & Dorman 
identified seven aspects that improved IS outcomes: early goal directed therapy, 
appropriate and timely administration of antibiotics, availability of blood culture results, 
source control, appropriate assessment and use of drotrecogin alfa ( a drug class with 
anti-thrombotic, anti-inflammatory and profibrinolytic properties), appropriate 
assessment and treatment of adrenal insufficiency, and intensive glucose control. 
Michaels & Dorman found many elements of IS guidelines were not implemented during 
their review period. The mean percentage of adults with sepsis that received evidence 
based therapies were as follows: appropriate administration of broad-spectrum antibiotics 
48.9%, timely administration of broad-spectrum antibiotics 44.2%, appropriate 
assessment of adrenal insufficiency 22.6%, appropriate use of steroids 31.2%, appropriate 
assessment for drotrecogin alfa 25.4%, appropriate use of drotrecogin alfa 73.5%, 
availability of blood culture results 49.1%, appropriate use of vancomycin 50.0%, 
discontinuation of vancomycin within 96 hours 40.0%, and implementation of tight 
glucose control 19.3% (Michaels & Dorman, 2004). The researchers proposed that by 
using the guidelines, the increasing mortality rate of sepsis can be largely reduced. 
Although a small sample, this study demonstrates the wide variability of guideline 
implementation in this small sample of ICU patients. 
 Lin et al., 2009 conducted a retrospective study examining 621 bacteremic adults 
in the emergency department at a university hospital from January 2007 through 
December 2007. The study was conducted to describe bacteremic adults presenting to 
emergency departments and identify risk factors for mortality. The data collection 
included age, sex, underlying illness, clinical condition, microbiology, source of 
bacteremia, and patient outcomes obtained from electronic medical records. The most 
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common underlying illness identified was DM (39.3%). Mortality rates were as follows: 
three day mortality 4.0%, seven day mortality 6.8%, 14 day mortality 10.3%, 21 day 
mortality 11.4%, and 28 day mortality 12.6%. Most frequently isolated pathogen was 
Escherichia coli (39.2%), and the most common source of bacteremia was urinary tract 
infection (41.2%) followed by primary bacteremia (13.2%). The overall 28-day mortality 
rate was 12.6%. Independent predicting factors for 28-day mortality in bacteremic adults 
included: age, malignancy, liver cirrhosis, alcohol use, polymicrobial bacteremia, anemia, 
and sepsis. Lin et al. noted the importance of identifying the risk factors that contribute to 
mortality in bacteremic adults within the ED setting. Limitations of the study include 
inconsistencies among completeness of data in medical records and additional risk factors 
not identified or explored (Lin et al., 2009). 
Diabetes Mellitus 
 In 2012, the incidence of a new diagnosis of DM was 1.7 million with a total of 
29.1 million Americans already living with DM accounting for 9.3% of the US 
population.  DM remains the seventh leading cause of death in America and a total of 
234,051 death certificates listed DM as an underlying or contributing cause of death in 
2010. DM is underreported as a cause or contributing factor of death, only 35%-40% of 
people with diabetes had diabetes listed anywhere on the death certificate. After adjusting 
for population age and sex differences, average medical expenditures among people 
diagnosed with DM were 2.3 times higher than without DM (American Diabetes 
Association, 2015). 
 The pathophysiology of DM is complex due to the different etiologies causing the 
similar symptoms, signs and complications. The disease can be classified by etiology and 
pathology as Type 1 Diabetes Mellitus (T1DM), Type 2 Diabetes Mellitus (T2DM), 
“other”, and gestational diabetes mellitus (GDM). The category of “other” consists of 
many problems but accounts for less than 1% of people with diabetes. GDM affects 5% 
to 6% of pregnant women and in most instances is an early form of T2DM. T1DM 
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consists of 5% to 10% of people with DM, and T2DM accounts for the remainder of the 
population, approximately 90%. In all cases of DM, the underlying denominator is the 
deficiency of the hormone insulin. Although T1DM is commonly known as a genetic 
disorder, new research is finding multiple environmental contributors to the development 
of the disease, including coxsackie viruses. Research is still ongoing to discover other 
environmental precipitating factors. The believed etiology of the pathophysiology of 
T2DM is still evolving daily with ongoing research.  T2DM is not a single disease but a 
group of diseases or syndromes with different genetic, environmental and 
pathophysiology factors that have similar symptoms and outcomes. Simplified, T2DM is 
a combination of insulin resistance and insulin deficiency. Genetic factors contributing to 
T2DM are still being identified, but environmental factors are well known including age, 
sedentary lifestyle, and obesity (Guthrie & Guthrie, 2004).  
Proper care of critically ill adults with DM will greatly reduce morbidity and 
mortality. The use of IV insulin, proper attention to fluid and electrolyte management, 
frequent neurological exams, and careful physical, electronic, and laboratory monitoring 
is necessary for ideal outcomes.  Adults with elevated glucose levels will often be 
profoundly dehydrated and very insulin sensitive. Controlled administration of fluids and 
control of blood glucose levels are mandatory to obtain optimal care of critically ill adults 
(Guthrie & Guthrie, 2004).  
Hospitalized adults with T2DM may benefit from tight glycemic control to 
prevent hyperglycemia and complications from high glucose levels. Johnston & Horn 
(2011) conducted a retrospective study to compare two groups of inpatients with diabetes 
receiving subcutaneous insulin via a basal-bolus approach or sliding scale. The study was 
conducted at a single medical facility in North Carolina, a total of 45 charts were 
reviewed with the following inclusion criteria: admission to the hospital within the prior 
year, history of T2DM, length of stay greater than four days, inpatient insulin 
administration, oral diabetic medication, and septicemia without mechanical ventilation. 
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Exclusion criteria were: admission for surgical procedure, inpatient prescriptions of 
steroids, thiazide diuretics or niacin, receipt of enteral feeding or total parenteral 
nutrition;  diagnosis of renal failure, liver failure, chronic obstructive pulmonary disease, 
diabetic ketoacidosis, or pancreatitis, admission to intensive care unit, or inpatient 
prescription of intravenous insulin. Data collected included age, weight, height, sex, race, 
date of admission, length of stay, discharge diagnostic related groups, inpatient oral 
diabetic medications, and insulin prescriptions, blood glucose values, and home diabetic 
medications. Four blood glucose results were collected for each subject daily for three 
consecutive days. Results from the study indicated 49% of adults received basal plus 
correction insulin, and 51% received correction insulin only. Out of 540 capillary blood 
glucose (CBG) results collected in total, 56% were classified as hyperglycemic events 
and 1% hypoglycemic events. In the basal plus correction insulin group 70% were 
considered hyperglycemic, while in the correction only insulin group 42% were 
considered hyperglycemic. Johnston & Horn concluded that greater than 50% of the 
blood glucose levels collected were considered hyperglycemic events indicating optimal 
glucose control a continuous problem throughout the day and not just an isolated event. 
These findings support the need for a change in practice in order to improve the glucose 
levels while adults are hospitalized. Study limitations include a small sample size, use of 
oral glycemic medications impacted CBG results, varying levels of diabetes, and 
additional unmeasured variables that could affect blood glucose levels such as pre-
existing co-morbidities and physiologic stress during hospitalization (Johnston & Horn, 
2011).  
Hyperglycemia Stress Response  
 Hyperglycemia is defined as having a fasting blood glucose level greater than 106 
in healthy adults and greater than 110 in critically ill adults (Thompson, 2008). The 
effects and long term impact of hyperglycemia on non-diabetic adults is less understood 
than diabetic adults.  Specifically, it is unclear if the association of hyperglycemia and 
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mortality in non-diabetic adult is related to the toxic effects of hyperglycemia or if the 
hyperglycemia is an indication of stress and can be related to severity of illness (Schuetz, 
Castro, & Shapiro, 2011). Historically, hyperglycemia has been viewed as a normal 
response to stress in critically ill adults. Treatment often is not initiated unless blood 
glucose levels exceed 200 to 250 mg/dl. The specific mechanisms by which 
hyperglycemia contributes to poor outcomes are not yet known. However, research 
demonstrates that intensive insulin therapy targeting euglycemia reduces morbidity and 
mortality in critically ill adults (Digman, Borto, & Nasraway, 2005).  
Schuetz, et al. (2011) conducted a systematic review of 15 studies examining the 
evidence from preclinical findings and clinical trials to determine whether DM has an 
impact on sepsis pathophysiology, susceptibility and or clinical outcomes. The 
researchers found a relationship between hyperglycemia and sepsis in diabetic and non-
diabetic adults. They also concluded that insulin provides more than one protective effect. 
Insulin not only lowers glucose levels, it has a direct effect on cell function and the 
physiologic response to infection. The reviewers were unable to conclude if adults with 
DM have worse outcomes then non-diabetic adults. Schuetz et al. purposed future studies 
focusing on diabetes as a syndrome, considering important confounding factors such as 
hyperglycemia, obesity, secondary micro- and macrovascular complications, insulin 
therapy, endothelial dysfunction to better understand the complexity DM and sepsis has 
in adults. No limitations were identified in the study. 
Schuetz, Jones, Howell, Trzeciak, Ngo, Younger, Aird, & Shapiro (2011) 
conducted a prospective study with three independent cohorts from two large tertiary care 
centers. The study included a total of 7,754 adults admitted to the hospital from the 
emergency department with suspected infections. The participants were observed for an 
association between diabetes and mortality rates. The study adjusted for age, sex, disease 
severity and sepsis syndrome. Results indicated a 4.3% morality rate 95% CI [3.9% to 
4.8%], with similar findings in diabetic and nondiabetic adults, 4.1% versus 4.4% 
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absolute risk difference (0.4%; 95% CI [0.7% to 1.4%]). There was no significant 
association between DM and mortality in adjusted analysis (odds ratio [OR] 0.85; 95% 
CI [0.71 to 1.01]). However, diabetes significantly modified the effect of hyperglycemia 
and hypoglycemia with mortality; initial glucose levels higher than 200 mg/dl were 
associated with higher mortality in nondiabetic patients (OR 2.1; 95% CI [1.4 to 3.0]) but 
not in diabetic patients (OR 1.0; 95% CI 0.2 to 4.7), whereas glucose levels less than 100 
mg/dl were associated with higher mortality in diabetic adults (OR 2.3; 95% CI 1.6 to 
3.3) and to a lesser extent in nondiabetic adults (OR 1.1; 95% CI 1.03 to 1.14). Although 
no significant association was found between diabetes and mortality rates within the 
adjusted analysis, the researchers reported an increased mortality rate for non-diabetic 
adults with elevated initial blood glucose levels. Limitations to study included adults 
prospectively enrolled according to suspicion of infection at ED evaluation, thus the 
study did not integrate longitudinal information and some adults ultimately found to have 
a noninfectious diagnosis may have falsely been included. The study did not include type 
and duration of diabetes or weight of adult, which could provide further insight (Schuetz 
et al., 2011).  
Hyperlactatemia 
 A marker for metabolic stress response is hyperlactatemia. The severity and 
duration of hyperlactatemia are related to mortality in critically ill adults. Increased 
lactate production can occur from tissue hypoxia, or as a response to inflammatory 
mediators, catecholamines, and other factors affecting sodium potassium and adenosine 
triphosphatase activity. Conditions such as severe sepsis can be indicated by 
hyperlactatemia (Revelly, Tappy, Martinez, Bollmann, Cayeux, Berger, & Chiolero, 
2005). 
  A retrospective chart review was conducted by Green, et al. (2012) from 2007 
through 2009 at an urban teaching hospital. A total of 1, 236 ED adults were included to 
determine if an association exists between hyperglycemia, hyperlactatemia and mortality 
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rates. Study subjects were identified from emergency room encounters. The data was 
collected from the electronic medical records (EMR). Nondiabetic adults, suspected to 
have an infection, with two or more systemic inflammatory response syndrome (SIRS) 
criteria, and simultaneous lactate and glucose testing in the ED, were included in the 
review. Two logistic regression models were created to determine if coexisting 
hyperlactatemia affects hyperglycemia’s association with mortality. A total of 9.3% of 
adults were hyperglycemic, 13% were hyperlactatemic, and 17% of adults died. The 
researchers concluded septic nondiabetic adults did not have higher mortality rates due to 
hyperglycemia unless associated with coexisting hyperlactatemia (95% confidence 
interval, (OR = 3.96, 95% CI [2.01 to 7.79]). Limitations of the study include selection 
bias as patients were previously identified and categorized, the data collected may have 
led to misclassification. Due to retrospective data collection, illness severity score was 
not able to be used. A further limitation is that adults were not followed prospectively 
after discharge to account for mortality rates after illness (Green, et al. 2012). 
 A prospective observational study by Revelly, et al. (2005), was conducted to 
evaluate the relative importance of increased lactate production as opposed to decreased 
lactate utilization in hyperlactatemic adults in the relation to glucose metabolism. The 
study took place in an ICU of a university hospital and consisted of seven adults with 
severe sepsis, seven adults with cardiogenic shock, and seven healthy volunteers. 
Interventions consisted of infusing sodium lactate at 10 umol/kg/min and then 20 
umol/kg/min over 120 minutes each to all study subjects, for a total of 2 infusions. 
Glucose was infused throughout the duration of the infusions of lactate. Baseline arterial 
lactate levels, heart rate, blood pressure, and cardiac index were all obtained prior to 
infusion and every 60 minutes post infusion, to observe glucose turnover and lactate 
conversion to glucose, for a total of 12 hours. Plasma glucose and insulin concentrations 
were monitored. Oxygen consumption and CO2 production were measured before and 
after infusions. The researchers found that baseline arterial lactate was higher in patients 
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with severe sepsis (3.2 + 2.6) or cardiogenic shock (2.8 + 0.4) than in healthy volunteers 
(0.9 + 0.20 mmol/L, p < 0.5). Lactate clearance was similar in all three groups: severe 
septic 10.8 + 5.4, cardiogenic shock 9.6 + 2.1, and healthy volunteers 12.0 + 2.6 
ml/kg/min. Endogenous lactate production, determined as the initial lactate concentration 
multiplied by lactate clearance, was markedly enhanced in septic adults (26.2 + 10.5) and 
cardiogenic adults (26.6 + 5.1) compared to healthy volunteers (11.2 + 2.7 umol/kg/min, 
p < 0.1). Conclusively both, septic and cardiogenic adults had increased lactate 
production concomitantly to hyperglycemia, and increased glucose turnover, indicating 
that hyperglycemia substantially influences lactate metabolism during critical illness. 
Limitations to the study were small sample size and pharmacokinetic evaluation of lactate 
metabolism relies on a study of basal lactate concentrations.   
 Lactate testing in septic adults is now a key component to the Surviving Sepsis 
Campaign (SSC). The National Quality Forum (NQF) ratified the measures for the 
treatment and management of adults with severe sepsis and septic shock as submitted 
collaboratively by the Henry Ford Hospital, the Infectious Diseases Society of America, 
and the Society of Critical Care Medicine.  Measures ratified by NQF are considered by 
the Centers for Medicare and Medicaid (CMS) for public reporting and payment 
programs. The NQF’s adoption of the SSC guidelines means that lactate measurements in 
severe sepsis could be included in quality measures for public reporting and 
reimbursements. 
  Rhee, Murphy, Platt & Klompas (2015) conducted a retrospective cohort study to 
analyze lactate testing in suspected septic adults over a span of 11 years. The purpose of 
the study was to measure the trends of lactate testing in septic patients. The study took 
place in two U.S. academic hospitals and included adult septic patients admitted from 
2003 to 2013. The annual rates of lactate measurement were assessed in severe septic 
adults who had blood cultures ordered. Results of the study found rates of lactate 
measurement in hospitalized adults with blood culture orders increased from 11% in 2003 
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to 48% in 2013 (p < 0.001 ). Rates of repeat lactate measurement within 6 hours after 
lactate levels greater than or equal to 4.0 mmol/L increased from 23% to 69% (p < 
0.001). In 2003, 49% of adults were on vasopressors (intravenous blood pressure therapy) 
at the time of first lactate measurements versus 21% in 2013 (p < 0.001).  Despite these 
trends, in 2013 only 65% of adults with severe sepsis had lactates measured at the time of 
suspected sepsis. On multivariate analysis, hospital-onset sepsis and hospitalization on a 
nonmedical service were common predictors for failure to measure lactates (adjusted 
odds ratio, 7.56; 95% CI [6.31-9.06] and adjusted odds ratio, 2.08; 95% CI [1.76-2.24], 
respectively). The researchers found hospital-onset sepsis and nonmedical units are still 
suboptimal in measuring serial lactate levels in septic adults despite SSC guidelines 
(Rhee, Murphy, Platt & Klompas, 2015).  
Risk for Development of Type II Diabetes 
 A prospective study by Gornik, Vujaklija, Lukic, Madzarac & Gasparovic, (2010) 
was conducted on 744 septic adults, of which 584 were without preadmission diagnosis 
of diabetes. The purpose of the study was to identify adults at risk for developing T2DM 
post hyperglycemia during sepsis encounter. It is common for septic adults to develop 
hyperglycemia as it is a result of the inflammatory response to stress and severity of 
illness, however not all severely ill adults will develop hyperglycemia. Those in the study 
who had hyperglycemia and were non-diabetic were found to be at four time’s greater 
risk of developing T2DM five years after illness. Of the 584 adults without diabetes 
preadmission 55 developed diabetes within the five year follow-up. The relative risk for 
developing T2DM was 4.29 (95% CI [1.35 – 13.64]). The researchers found incidences 
of hyperglycemia to be a risk factor for developing T2DM and proposed that adults 
within this high-risk population should be followed up closely for the development of 
diabetes. Limitations include size of study group and follow-up group. Larger study 
group with longer follow-up is recommended for further research (Gornik et al., 2010). 
Intensive Insulin Therapy 
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 A recommendation from Surviving Sepsis Campaign recommends blood glucose 
of less the 150mg/dL. One way of achieving normoglycemia is with intensive insulin 
therapy (IIT). Intensive insulin therapy is a term used to describe tight management of 
blood sugar levels. The regimen to manage diabetes in this way includes frequent testing 
and either regular administration of insulin or use of an insulin pump (American Diabetes 
Association, 2015). Most critically ill adults benefit greatly from the use of IIT.  
However, researchers report similar findings of high risk for hypoglycemia with little to 
no difference in mortality rates compared to adults with moderate hyperglycemia, defined 
as glucose level between 140mg/dL and 180mg/dL (Surviving Sepsis Campaign, 2015). 
Thompson (2008) conducted a systematic review of intensive insulin therapy in 
septic adults. The review included 60 individual studies which focused on key points 
including: stress hyperglycemia, IIT, early treatment of glucose control, (renal protective) 
mechanisms, hypoglycemia, variability of protocols, assessing glucose control and 
amount of time for nurses to manage glucose control. Stress-induced hyperglycemia was 
found to be associated with an increase in the risk of death, congestive heart failure, 
cardiogenic shock after myocardial infarction and an increase in mortality after ischemic 
stroke. Hyperglycemia was observed to be an independent predictor of poor outcomes, 
the cause-effect relationship still remains unclear. The authors observed a significantly 
improved outcome when stress hyperglycemia was controlled within 48 hours of critical 
illness. Also noted by researcher as a study limitation, glucose values that were tested by 
point of care capillary blood glucose may overestimate arterial blood glucose when 
values are low and the degree of overestimation can impact the clinical treatment. 
According to the authors, it remains unclear if the hypoglycemia experienced from IIT is 
related to short term mortality. The study proposes guidelines which include the use of a 
validated insulin titration protocol, glucose monitoring every one to two hours, and the 
provision of a caloric source while on insulin therapy (Thompson, 2008). 
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A prospective study by Lorencio et al, 2012 assessed the accuracy of a real-time 
continuous glucose monitoring system within an ICU to determine if the status of the 
septic adult was influenced by the accuracy of the adult’s blood glucose. The researchers 
monitored 41 adults over the course of 72 hours. Adults included in the study were 
admitted to the ICU with glucose levels greater than 150mg/dl. The insulin protocol 
established by the ICU of the hospital was used to obtain glycemic control for the study 
subjects. Arterial blood samples were taken every 30 minutes until a stable level was 
reached and then taken every one, two, three or four hours thereafter for monitoring. 
Adults under the age of 18, pregnant, or who had participated in another study, were 
excluded in the study. The researchers propose that adults with septic shock had impaired 
interstitial glucose, therefore improper glucose control can occur without the use of real-
time continuous glucose monitoring (RTCGM) directly from the blood stream. Study 
limitations included small sample size, degree of edema or tissue perfusion was not taken 
into account, and placement of RTCGM. The authors concluded from the research 
findings that in septic adults, RTCGM was most accurate at 74.5% (P < 0.05) when 
compared to arterial blood glucose samples (Lorencio et al, 2012).  
 A study by Van Den Berghe (2003) compared normalization of glucose for 
diabetic and non-diabetic adults in a prospective observational study. The purpose of the 
study was to determine if hyperglycemia predisposes adults to common ICU 
complications and was not a beneficial adaptation to severe illness. The study compared 
1,548 ICU ventilated septic adults within two university hospitals, 14.7% of the adults 
had the pre-diagnosis of diabetes. A randomly assigned intensive insulin therapy group 
received insulin infusion to control blood glucose levels between 80-110 mg/dl. The 
conventional treatment group received insulin only in the event that blood glucose levels 
exceeded 200 mg/dl. Results from the study showed the intensive insulin therapy group 
had a 43% (p = 0.036), reduction in intensive care mortality, a 34% (p = 0.005), reduction 
in hospital mortality reduced risk of severe infection by 46% (P = 0.003), and a 35% (p < 
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0.001) reduction in prolonged (greater than 10 days) antibiotic use. Limitations of the 
study included that the population was limited to ICU intubated septic adults only and 
was not applied to medical ICU, children ICU or surgical adults on medical wards (Van 
den Berghe, 2003). 
Glucose Variability 
 Spapen (2008) compared glycemic variable in adults with sepsis. The study was a 
retrospective review of data from two landmark studies, examining 950 adults admitted 
to the ICU with sepsis. Adults were divided into two groups, one group consisting of 471 
adults received conventional sliding scale insulin and the other group included 479 adults 
who received IIT. Hyperglycemia was found to be a common finding in septic adults. 
Factors that increased the risk for hyperglycemia were presence of insulin resistance, 
high circulating levels of stress hormones and therapies that promoted hyperglycemia 
such as steroids, continuous enteral nutrition feedings, and dextrose infusions. The study 
results indicated that septic adults had a significant increase in hypoglycemic events 
(19.6%) compared to non-septic adults (6.8%) when receiving IIT. The researcher 
observed glucose variability measured by the Glycemic Lability Index as best tool for 
predicting hospital mortality. The Glycemic Lability Index is defined as the squared 
difference between consecutive glucose measures per unit of actual time between those 
samples. Glucose variability, as identified by the index, was associated with increased 
hospital mortality independent from relevant clinical factors such as hypoglycemia, 
degree of organ failure, intensity of glucose testing, and treatment. No limitations were 
identified in the study (Spapen, 2008).  
Ali et al. (2008) conducted a study to determine if septic adults are more prone to 
hyperglycemia and insulin resistance due to the number of pathophysiologic changes 
caused by the release of catecholamines, cortisol and glucagon associated with sepsis. 
The purpose of the study was to assess the association of glucose variability and hospital 
mortality in septic adults. The study was a retrospective chart review from a single-center 
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cohort at a tertiary care hospital with no sepsis interventions. The study included 1,246 
adults hospitalized for more than one day with a diagnosis of sepsis. Excluded from the 
study were hospital readmissions, prisoners, and adults with limited glucose data. Results 
of the study showed glycemic lability index had the best discrimination for mortality 
(AUC = 0.67, p < 0.001). After adjustments for confounders such as organ failure and 
hypoglycemic events, Ali et al, found a significant interaction between glycemic lability 
index, average glucose level, and the odds of hospital mortality. Adults with increased 
glycemic lability index and lower average glucose values had almost a five-fold increased 
odds of hospital mortality (OR = 4.73, 95% [CI 2.6 to 8.7]). The researchers concluded 
glucose variability to be an independent factor in mortality rates and a need for future 
research to support the findings of glucose variability to be a new “gold-standard” in 
adults diagnosed with sepsis. Limitations are as follows: unable to determine timing of 
organ failure with respect to onset of sepsis, glucose variability, or other unmeasured 
factors. The study did not use a physiology-based severity of illness score for risk-
adjustment and missing information about other treatments adults may have received (Ali 
et al., 2008). 
Diabetes and Sepsis 
 Diabetes has a high prevalence and a potential to alter critical elements of the 
pathophysiology of sepsis. Diabetic adults have an increased susceptibility to infection 
and risk of dying from an infectious disease. Inflammatory and coagulant pathways that 
are activated during sepsis are also noted to be concurrent in diabetic adults without 
infection.  Clinicians believe urinary tract infections to be more common among adults 
with diabetes and more severe cases leading to pyelonephritis and bacteremia (Kefteridis, 
Papadimitraki, Mantadakis, Maraki, Papadakis, Tzifa, & Samonis, 2009).  
A retrospective chart review was conducted by Kefteridis, et al. (2009) at a 
university hospital. Participants consisted of 88 adults aged 65 and older with diabetes 
and 118 adults without diabetes. The researchers reviewed charts from January 1997 
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through December 2005 of adults hospitalized for acute pyelonephritis. Demographic, 
clinical and microbiological data was collected from the medical records. Of the study 
subjects, 27 (30.7%) diabetic and 13 (11.0%) non-diabetic adults developed bacteremia 
(p = 0.001). The researchers found that subjects with diabetes had a fever for longer 
periods of time (4.5 versus 2.5 days; p < 0.001), longer hospitalization (10 days versus 7 
days; p < 0.001), and greater mortality rates (12.5% versus 2.5%; p <0.01) than those 
without diabetes. Limitations of the study include different treatment from physicians 
over the course of nine years, lack of data regarding DM treatment, and the lack of prior 
antimicrobial consumption data (Kefteridis et al., 2009). 
A retrospective chart review by Yang, Salam, Ong, & Yang (2011) was 
completed to compare the organ dysfunction between diabetic and nondiabetic adults. 
The study reviewed 9,221 charts from Singapore General Hospital in the years 2004 to 
2008, 2943 (31.9%) being diabetic adults. Study participants were greater than 18 years 
or older. The collected data included demographic information such as ethnicity, age, 
marital status, gender, dates of admission and discharge, dates of ICU admission and 
discharge, up to 10 ICD-9 codes, discharge status, and disposition at discharge. The most 
common organ dysfunction in septic adults were renal (31.5%), cardiovascular (19.2%), 
and respiratory (10.9%). Among these septic adults, respiratory dysfunction was less 
likely in diabetic adults (9.4%) than in nondiabetic adults (11.6%; p = 0.002). Renal 
dysfunction was more likely in diabetic adults than nondiabetic (46.5% versus 24.4%; p < 
0.001). The diabetic adults in the study had equal hospital lengths of stay, 12.1 days 
compared to 12.2 days and mortality rates 19.2% vs 20.0% in non-diabetic adults. The 
researchers found protective effects of diabetic adults with good glycemic control before 
developing sepsis. Limitations of the study include coding errors of data and omission of 
important diagnoses and complications, conditions that could have affect results. Other 
limitations include large population over multiple years (Yang et al, 2011).  
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Stegenga et al. (2010) conducted a retrospective analysis on adults admitted with 
sepsis involving 837 ICU adults in 164 different centers. The purpose of the study was to 
determine if the presence of diabetes adversely affects the outcome of sepsis. The 
researchers divided adults with suspected infection into two groups: diabetic and non-
diabetic. The subjects had to have three or more signs of systemic inflammation. 
Mortality was assessed after 28 and 90 days and, the infectious agent, markers for 
coagulation and fibrinolysis were measured throughout the study. In total 22.7% of septic 
adults were diabetic. Throughout the length of stay in the hospital, diabetic adults had 
higher glucose levels. At 28 days mortality rates were equal for diabetic adults and non-
diabetic adults (31.4% and 30.5%). Although upon admission diabetic adults had slightly 
higher markers of coagulation, fibrinolysis, and inflammation, and they were generally 
equal between diabetic and nondiabetic adults during hospitalization. Subjects without 
diabetes with admission hyperglycemia were associated with higher mortality rates than 
subjects without admission hyperglycemia (43.0% versus 27.2%).   A limitation of study 
was that the two cohorts were not totally equal in age, APACHE II score, and organ 
dysfunction at baseline. Discrimination between stress hyperglycemia and undiagnosed 
diabetes in nondiabetic group, HbA1c would have been valuable. No data was available 
on type of diabetes, nor any documentation on diabetes complications (Stegenga et al, 
2010).  
 In conclusion, further analysis of the correlation between hyperglycemia and 
sepsis is needed. The majority of the studies demonstrate that the strict control of glucose 
decreased the morbidity and mortality of critically ill adults. However, insulin therapy 
carries an increased risk of hypoglycemia which can be more detrimental then 
hyperglycemia in some adults. The majority of the studies also discussed protective 
measures of insulin therapy with diabetic adults and indicated a greater need to 
investigate the effects of hyperglycemia within the septic non-diabetic adult. Lastly non-
diabetic adults need to be closely monitored post-infection for the increased risk of 
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developing diabetes type II (Gornik et al., 2010). There is a continued need to study the 
effects of hyperglycemia within the septic adult and the concurrent effects on lactate 
levels.  
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Theoretical Framework 
 The theory of General Adaptation Syndrome (GAS), a borrowed theory from 
behavioral sciences and physics was the theoretical framework used to guide the research 
study. Hans Selye, a Hungarian endocrinologist, first used the term ‘stress’ to describe a 
biological reaction to homeostasis while researching the effects of hormones on rats. 
Selye pioneered research on stress and developed the GAS theory in 1956. Selye 
theorized that stress is a major cause of disease and chronic stress causes long-term 
chemical adaptations. Stressors can greatly influence normal metabolism leaving a 
limited supply of adaptive energy (Selye, 1950).  
            Based on physiology and psychobiology, the stress model can be explained in 
three stages of the general adaptation syndrome: alarm, resistance and exhaustion. In the 
first stage the body reacts with "fight or flight" response with the activation of the 
sympathetic nervous system upon encountering a stressor. Hormones such as adrenalin 
and cortisol are released into the blood stream to help the body fight the stressor 
(McEwens & Wills, 2011). During the first phase, most adults compensate and maintain 
homeostasis, thus making identifying sepsis difficult. The first stage may be identified as 
blood glucose levels start to rise, while the adult remains at an increased level of alertness 
and anxiety begins. 
In the second stage, the body responds and compensates with the parasympathetic 
nervous system. As the body attempts to return physiological function to normal, the 
blood glucose levels remain high. Cortisol and adrenalin continue to circulate through the 
body at elevated levels causing increased heart rate, blood pressure and breathing. The 
second stage can be identified as adults continue with high levels of glucose (McEwens 
& Wills, 2011).  
 At the end of the second stage, the body will remain "on alert" exhausting 
biological reserves and becoming susceptible to disease and death in the last stage of the 
stress response. The last stage occurs when the stressor cannot be neutralized. Due to the 
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long duration of the stressor the body becomes overwhelmed by the stressor and can no 
longer compensate to maintain homeostasis. The body becomes dysfunctional and can 
display a multitude of psychopathologic symptoms such as disorganized thinking, change 
in personality, delusions, hallucinations, stupor, or violence.  The last stage can be 
displayed when the adult is at its highest stress level and notably at an unstable 
hemodynamic level as evidence by glucose and lactate levels (McEwens & Wills, 2011). 
 Response to stressors can be predicted from the three phases within the General 
Adaptation Syndrome. The theory supports the study by explaining how the stress of 
infection will impact the glucose levels. Additionally, Selye (1950) observed that even 
when one's body wants to control or reduce the stress, the ability is limited. The supply of 
the body's energy is limited in adapting to the stressful environment and is even more 
compromised when the body is continuously exposed to the stressor. The theory gives 
explanation and guidance in predicting an adult’s response in a stressful event such as IS. 
Knowing the predicted responses Selye has identified in GAS, combined with the  
findings of this research, changes in the current sepsis protocol related to optimal glucose 
management in IS maybe well supported (McEwens & Wills, 2011). 
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Method 
Purpose 
 The purpose of the research study was to identify if a relationship exists between 
hyperglycemia, lactatemia, length of hospital stay and mortality in adults with preexisting 
DM and IS. The relationship was identified by comparing the glucose and lactic acid 
levels within the first 48 hours of the hospitalization of the septic event	with hospital 
length of stay and mortality rates. The researcher proposed that individuals with higher 
glucose levels would have an increase in lactic acid levels resulting in longer lengths of 
stay and higher mortality rates than those who have a tighter glucose control as defined 
by a glucose level between 80 and 180mg/dl.   
Research Question 
 The research question was: What is the relationship between hyperglycemia and 
hyperlactatemia on hospital length of stay and mortality based on preexisting diabetes in 
adults admitted to the emergency department with infectious sepsis? 
Design 
 The project was a quantitative descriptive study done through a retrospective 
chart review. Group A included subjects with no existing diagnosis of DM who met the 
inclusion criteria, to which a collection of lab values, length of stay and mortality data 
was collected. Group B included subjects with existing diagnosis of DM who met the 
inclusion criteria, to which a collection of lab values, length of stay and mortality data 
was collected. The data from both groups were compared and evaluated to distinguish if a 
relationship existed between elevated glucose levels and lactic acid levels, length of stay 
and mortality rates.  
Site 
 The data collection took place at Charlton Memorial Hospital (CMH) in Fall 
River, Massachusetts. The hospital is a nonprofit, non-teaching community hospital that 
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is licensed for 285 beds, of which 25 are critical care. Currently CMH evaluates and 
treats approximately 500 septic patients per year. 
Sample 
 The sample included adults between 18 and 90 years of age, admitted with the 
diagnosis of sepsis, recruited from a data base of adults with ICD codes of sepsis with 
and without previous diagnosis of diabetes.  Excluded were pregnant patients, prisoners, 
and adults with more than five comorbid conditions. The number of charts reviewed were 
146 to obtain two sample groups of 25. Group A included adults diagnosed with diabetes 
and Group B included non-diabetics adults with sepsis.  
Measurement 
 A data collection instrument (Appendix A) designed by the student researcher 
included the following data points: age, serum glucose and serum lactate, diabetes 
diagnosis, insulin therapy (none, IV infusion, sliding scale), length of stay (LOS) and 
evidence of hospital mortality. De-identified data collected was entered into an Excel 
spreadsheet and kept in a locked locker which only the researcher and facility advisor had 
access to and confidentiality was maintained.  
Ethical Considerations 
 Ethical considerations for the research study included patient confidentiality. 
Adults were identified as numbers 1-25 in Group A and Group B, for a total of 50 adults. 
All recorded information was secured in a confidential folder located in a locked locker. 
There was no discrimination for race, age or gender. Institutional review board (IRB) 
approval was obtained from Rhode Island College and was used according to Southcoast 
Health System Federal Wide Assurance (FWA).  
Procedure 
 CMH leadership support was obtained from the Assistant Chief Nursing 
Officer in the form of a written letter (Appendix C).  Hospital Information Technology 
division was contacted for access to EMR for systematic chart reviewing in order to 
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locate and approve charts coded by ICD 9 code 995.91 for sepsis. IRB approval was 
obtained from Rhode Island College and was used according to Southcoast Health 
System FWA. The chart reviews took place in CMH library. The data retrieved was 
stored in a folder labeled ‘confidential’ and kept in a locked locker in the nurse’s locker 
room. De-identified data was recorded into an excel spread sheets (Appendix A and 
Appendix B). The raw data was destroyed after completion of research study. 
Confidentiality of all data was maintained throughout research study. Data was accessed 
by the student researcher only. A total of 146 charts were reviewed between the dates of 
February 11, 2016 and February 25, 2016. The dates of the charts collected are between 
January 2015 and December 2015.  After all data was collected, results were evaluated.  
The research was presented to RIC School of Nursing in May, 2016. Results were also 
shared with the education council and policy review board at Charlton Memorial Hospital 
for review and revision of sepsis protocol. 
Data Analysis  
 Initial demographic and study variables were analyzed with descriptive statistics. 
Quantitative data was obtained for analysis to identify if any relationship exists between 
elevated glucose and lactic acid levels within the first 48 hours of septic illness, the 
length of stay and mortality rates of diabetic and non-diabetic patients with a septic 
illness. A range and mean age was calculated. Mean and standard deviation was 
calculated for length of hospital stay and mortality rates for both groups and compared. 
Data collected was presented in a table format. 
Enabling Factors and Barriers 
 Enabling factors included the support and guidance from Rhode Island College 
Faculty and Southcoast Hospital Groups Chief Nursing Officer. Limitations to the study 
were based on availability of charts with inclusion criteria, time of blood draws and if 
glucose and lactate levels are drawn concurrently. Other barriers included changing of 
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electronic medical records from Meditech software to Epic in October 2015, which 
created a barrier to readily obtaining previous medical charts.  
Timeline 
 Proposal to CMH was submitted November 10, 2015 and the RIC IRB November 
25th, 2015. Timeline of the research was from December 1, 2015 to February 28, 2016. 
Completion of report and findings by April 30, 2016. Presentation of project May 3, 
2016.  
Desired Outcomes 
 The desired outcomes of the research study were to identify if a relationship exists 
between hyperglycemia, hyperlactatemia, identifying severity of sepsis, hospital length of 
stay and mortality rate. The researcher will share the findings to support the 
implementation of glucose management to the existing sepsis protocol at Southcoast 
Hospital Groups to be current with national standards and Surviving Sepsis Campaign. 
Dissemination 
 The study findings were presented in May 3, 2016 at the Research Symposium  
held at Rhode Island College. The final report is accessible through the Electronic Digital 
Comments of Rhode Island College Library, with additional possible submission to the 
Critical Care Medicine Journal. Results of the research will be shared with CMH and 
may impact the sepsis protocol by implementing insulin administration into the sepsis 
protocol currently inplace. 
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Results 
 A total of 148 charts were reviewed; 56 charts were excluded because they did not 
meet the inclusion criteria. Another 42 were eliminated as the patients had developed IS 
after admission to the hospital as a secondary diagnosis. Thus, the remaining charts 
(n=50) were reviewed to identify if a relationship occurred between hyperglycemia and 
hyperlactatemia.     
 The age range of the adults were from 32 to 87 with a mean of 58.5 years. Group 
A, adults with preexisting diabetes presenting with IS included 50 percent (n=25) of the 
adults reviewed. The remaining 50 percent (n=25) were placed in group B which were 
adults without a preexisting diagnosis of diabetes.  
 Comparison of the three glucose mean levels, range, and standard deviation are 
listed in Table 1. The majority of the adults in group A were type II diabetics, however 
44 percent (n=11) were maintained on a sliding insulin scale for glycemic control. The 
remaining 56 percent (n=14) were maintained on oral glycemic agents. The adults in 
group B had no glycemic control throughout their hospital stay. The first glucose level 
was drawn on arrival to the emergency department, the second was drawn six hours later 
and the last glucose was drawn 48 hours after the initial level was drawn, all on the same 
time frame as the lactate levels.  
Table 1 
Serial serum glucose levels 
Group Mean 1 Range 1 SD 1 Mean 2 Range 2 SD 2 Mean 3 Range 3 SD 3 
A 183.2 73-436 86.875 191.92 84-546 92.991 127 75-283 48.019 
B 122.56 85-183 23.024 135.36 78-192 27.152 99.2 72-229 29.839 
 
 Comparison of the three lactate mean levels, range of lactate levels, and standard 
deviation are listed in Table 2. All adults were started on the sepsis protocol in the 
emergency department and administered weight based intravenous fluid administration in 
accordance to the protocol. The first lactate level was drawn on arrival to the emergency 
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department, the second was drawn six hours later and the final lactate level was drawn 48 
hours from the first.   
Table 2 
Serial serum lactate levels 
Group Mean 1 Range 1 SD 1 Mean 2 Range 2 SD 2 Mean 3 Range 3 SD 3 
A 2.684 1.5-5.5 0.733 2.192 1.2-3.3 0.625 1.384 0.8-2.6 0.495 
B 3.804 1.1-94 2.44 3.36 1.6-9.7 2.037 1.68 0.8-3.8 0.726 
 
 Figure 1 compares the mean glucose levels to the mean lactate levels in Group A. 
Figure 2 compares the mean glucose levels to the mean lactate levels in Group B.  Group 
A had higher glucose levels when compared to Group B, however Group B had higher 
lactate levels. There was a rise in the glucose level taken at the six-hour mark compared 
to the initial glucose level in both groups.  
 
Figure. 1. Serum glucose vs serum lactate levels in Group A.  
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Figure. 2. Serum glucose levels vs serum lactate levels in Group B. 
 Comparison of the mean length of stay in days, range of length of stay, and 
percentage of mortality rates are listed in table 3. Group A had no mortalities and a short 
length in stay when compared to Group B. There was a 12.5 percent (n=2) mortality rate 
in Group B and a higher in length of stay.   
Table 3 
Length of stay vs. mortality rates 
Group Mean LOS LOS Range Percentage of 
Morality 
A 8.28 5-17 0 
B 9.32 3-26 12.5 
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Summary and Conclusions 
Early identification and intervention is the gold standard for treatment of IS in adults 
presenting to the emergency department (CDC, 2016). IS continues to present in a 
complex manner making it difficult to identify and diagnosis. Septicemia is currently the 
sixth most common diagnosis requiring hospitalization in America (CDC, 2016). 
Between the years 2000 and 2008 the number of adults identified with sepsis doubled, 
reaching over one million Americas affected each year. Of the adults diagnosed with IS, 
one half of them will die from the infection. In 2009, sepsis was one of the most 
expensive hospitalizations, costing nearly 15.4 billion dollars (CDC, 2016).  
 As it is common to have stress-induced hyperglycemia during critical illness, the 
level in which the hyperglycemia becomes harmful is 180mg/dl or greater. The Surviving 
Sepsis Campaign continues to recommend maintaining a serum glucose below 180mg/dl 
in all septic patients with and without diabetes (Surviving Sepsis Campaign, 2016). 
Although the risk for diabetic patients to become septic is greater than a nondiabetic 
adult, the effects of hyperglycemia are equally as harmful. The effects of hyperglycemia 
on critically ill adults continues to be a leading cause of mortality in septic adults, thus 
supporting the recommendations of glycemic control (CDC, 2016).  
 The purpose of the study was to identify if a relationship exists between 
hyperglycemia, hyperlactatemia, hospital length of stay and mortality rates in adults with 
IS. It was proposed that adults with higher glucose levels would have higher lactate levels 
therefore increasing length of hospital stay and higher risk of mortality. The study was 
guided by the General Adaptation Theory (Salye, 1950). A retrospective chart review was 
conducted; 148 charts were reviewed of which 50 met the inclusion criteria. Group A 
(n=25) was defined as adults with preexisting diabetes. Group B (n=25) was defined as 
adults without a preexisting diagnosis of diabetes. The data showed that when the two 
groups were compared, Group A had higher glucose levels then Group B. Although 
Group B had higher lactate levels and an increase in hospital stay and a 12.5 percent 
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mortality rate within the group. Group A had a shorter length of stay with zero mortality 
within the group.   
 The researcher’s projected outcome was for Group B nondiabetic adults to have 
higher glucose levels leading to higher lactate levels and increasing the LOS and higher 
mortality rates. Although the results indicated Group B to have lower glucose levels, they 
did have higher lactate levels and longer LOS as well as a higher mortality rate. The 
results suggest Glycemic agents did not decrease glucose and could not determine if they 
had any protective effect for lowering lactate levels in Group A. The research did not 
prove a relationship between hyperglycemia and hyperlactate levels resulting in longer 
LOS and or higher mortality rates. As stated in Schuetz et al. (2011) study, insulin 
provides more than one protective effect. Insulin not only lowers glucose levels, it has a 
direct effect on cell function and the physiologic response to infection. Thus suggesting 
this in the study, although diabetic adults in Group A had higher glucose levels, the 
subjects in Group A had better overall post sepsis outcomes then nondiabetic patients in 
Group B, as evidence by shorter LOS and no mortalities within the study.   
Limitations 
 Limitations to the study include small sample size, availability of charts with 
inclusion criteria, time of blood draws and if glucose and lactate levels are drawn 
concurrently. Other limitations included changing of electronic medical records from 
Meditech software to Epic in October 2015, which created a barrier to readily obtaining 
previous medical charts.  
Ethical/Social Issues 
 No ethical issues at this time for the study, however social issues would be for 
access to medical care and proper glucose control for patients and ability for glycemic 
control.  
Quality Measures 
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 Quality measures for potential timing and accurate measures for obtaining blood 
sugar levels. Administration of glycemic agent and nursing competency on following IS 
protocol based on national standards.    
Cost Considerations 
 Minimal cost considerations for serum blood draws, increased nursing staff time 
to interpret protocol and administration of glycemic agent.   
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Recommendations and Implications for Advanced Nursing Practice 
 Advanced Practice Registered Nurses (APRN) have a responsibility to the 
critically ill adult to provide the best care according to evidenced based consensus 
statements by following the Surviving Sepsis Campaign recommendations of close 
glycemic control in the septic population regardless of preexisting diagnosis of diabetes. 
Prevention and management of sepsis the critically ill adult is complex and requires 
accurate identification of the onset of SIRS and diagnosis of IS. Specific to the findings 
in this study, APRNs can provide the implementation of evidence based protocols that 
includes use of glycemic control with all adults with IS. Methods for assessing, 
recording, and documenting a change or identification of vital signs, and evaluation of 
key laboratory findings must be clearly specified and evidence based.  
 Evidence based practice drives quality improvement, and benefits both the 
hospitals and the adults receiving care. Providing care considered to be the gold standard 
will contribute to a decrease in hospital LOS and decrease rates of IS mortality. Initiating 
glucose control for all adults with and without diabetes will not only improve the 
outcomes, but will cut down on long term costs and potential complications from 
prolonged hyperglycemia.  
 APRNs continue to advocate for patients and help improve education throughout 
healthcare facilities and implementing evidenced based practice. Contributing to 
advancement of policies and procedures related to IS will provide improved care 
management of patients and help health care systems to reduce cost. APRNs are in an 
ideal position to educate and become leaders, but also to continue to advocate for 
improved patient outcomes as part of an interdisciplinary team. Advocating for policy 
change to keep current with evidence based practice and research is one of the ways in 
which the APRN can change the trajectory of health and disease management. This study 
contributes to the evidence that hyperglycemia may negatively impact patient outcome in 
IS and the APRN has a role in translating current	research into optimal patient care.  
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